Disclosure under Regulation 30 of SEBI Listing Regulations - Acquisition

Board Approval and Transaction Details

The Board of Directors of Laurus Labs Limited at its meeting held on October 29, 2026 (commencing at 02:00 PM IST and concluding at 02:47 PM IST) approved the acquisition of 52% share capital of SI & C Resins Private Limited (SI&C) at a pre-money valuation of ₹30 crore.

The Company will invest a total of ₹32.50 crores by way of primary acquisition of 10,833 equity shares, equivalent to 52% of post-issue equity capital on closing. Post-acquisition, SI&C will become a subsidiary of Laurus Labs Limited.

Target Company Background

Name: SI & C Resins Private Limited

Location: Hyderabad, India

Date of Incorporation: July 15, 2026

Business: Specializes in manufacturing and supply of high-quality polymer and silica-based products for chemical, pharmaceutical, and biotechnology industries.

Product Applications:

  • Peptide and Peptidomimetic Synthesis
  • Absorption and separation of heavy metals
  • Oxidation and reduction of functional groups
  • Counter-ion exchange of small molecules and APIs

Turnover History: SI&C was incorporated recently and will take over the business of partnership firm M/s SI & C Resins. The firm had turnover of ₹3.55 crore for FY 2024-25 and ₹4.05 crore for FY 2025-26.

Strategic Rationale and Impact

The acquisition is part of Laurus Labs' overall peptide strategy and will make the company's offerings in peptide manufacturing fully integrated. The investment will bring synergy to Laurus Labs' business while SI&C continues to develop new markets for its products.

The acquisition will help in indigenous resins development, chromatography gels development, and large-scale manufacturing, enabling capture of fully integrated peptide manufacturing opportunities. SI&C will set up a large-scale manufacturing plant for peptide resins as solid phase peptide synthesis (SPPS) supports and chromatography gels.

Additional Investment Commitment

The Company may also invest up to ₹30 crores in securities to be issued by SI&C as and when funds are required by SI&C.

Regulatory and Transaction Details

Related Party Status: The acquisition does not fall within related party transactions. Promoter/promoter group/group companies of Laurus Labs have no interest in SI&C.

Government Approvals: The acquisition will be in accordance with applicable provisions of the Companies Act, 2013.

Transaction Timeline: Expected to be completed during the current financial year, subject to completion of customary closing conditions and agreements including transfer of business of the partnership firm.

Consideration Type: Cash consideration

Regulatory References: SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026